コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the adjunct solitary from the term solitary mastocytoma.
2 ammary adenocarcinoma, glioma, leukemia, and mastocytoma.
3 ntaneous transformation ex vivo; and P815, a mastocytoma.
4 n a malignant fashion, unlike human solitary mastocytomas.
6 s in both primary mast cells and transformed mastocytomas, although with a smaller IC(50) value in th
7 interfere with the GVT effect, because P815 mastocytoma and most importantly primary Bcr-Abl-transfo
9 mice transplanted with the immunogenic P815 mastocytoma and showed that it significantly enhanced th
10 ponse against two B7- tumors, the mouse P815 mastocytoma and the E7C3 melanoma, requires host-derived
12 analyses of non-T cells, including B cells, mastocytoma, and fibroblasts, by Northern blot analysis
16 r experiments using highly purified enzymes, mastocytoma cell chymase activated 92-kD progelatinase i
17 gical inhibition of CD39 in a cultured human mastocytoma cell line (HMC-1) and murine bone marrow-der
19 F) was expressed on the surface of the mouse mastocytoma cell line P815 to target tumor cell-associat
22 ty, we immunized PLRP2-deficient mice with a mastocytoma cell line, P815, and determined the ability
25 hat a metallogelatinase is secreted from dog mastocytoma cells and directly activated by exocytosed m
30 with different cell types, including murine mastocytoma cells in suspension culture, adherent NIH 3T
33 nase activity secreted by the BR line of dog mastocytoma cells reveals a phorbol-inducible, approxima
36 e presence of B7/BBl-transfected P815 murine mastocytoma cells underscoring an SLE-associated defect
39 t form expressed in pineal gland and in P815 mastocytoma cells with a molecular weight of 51 kDa.
41 coded by an abundant 4.6-kilobase mRNA, like mastocytoma cells, has 70% amino acid sequence identity
42 The current work demonstrates that dog BR mastocytoma cells, HMC-1 cells, and murine bone marrow-d
49 denosine-mediated degranulation of canine BR mastocytoma cells; and (iii) the BR cell A2BAR couples t
50 ain a cDNA encoding the complete sequence of mastocytoma gelatinase B, a 2.3-kilobase clone encoding
52 ned posttransplant relapse of the DBA/2 P815 mastocytoma in a murine model of MHC-matched, minor hist
53 tumor-specific CTL response against the P815 mastocytoma in the peritoneal cavity of preimmunized mic
56 strongly suggest that the above enzymes from mastocytoma, liver, and trachea, per se, are not solely
58 DTRs autoimmune (n = 18) and NDSTRs lymphoma/mastocytoma (n = 12) and 68 dogs for IL-2; healthy (n =
64 phoma (A20) cells, but not class II(-) mouse mastocytoma (P815) cells, supported IL-2 secretion of hy
65 15 minutes, in DBA/2 mice bearing either the mastocytoma, P815, which expresses the naturally occurri
66 NH2-terminal 13 amino acids of the purified mastocytoma progelatinase are 50-67% identical to those
67 liver NDANST that are conserved in the mouse mastocytoma protein produced three important findings re
68 d NIH 3T3 and some murine cancer cells (e.g. mastocytoma, sarcoma, and lymphoma), while lacking on ot
69 hows that cultured BR cells derived from dog mastocytomas secrete the 92-kDa proenzyme form of gelati
70 also following in vitro exposure of the P815 mastocytoma (that is negative for both B7-1 and B7-2 sur
71 timal primary tumor-specific CTL to the P815 mastocytoma, the EL4 thymoma, and the Lewis lung carcino
73 hibitor, dasatinib, on the c-KIT mutant P815 mastocytoma tumor were substantially dependent on T cell
75 t of mast cell neoplasms, we examined canine mastocytomas, which are among the most common tumors of